Table 1.
Variables | Women With Observed FMP Plus Lipids (n=1554) | Women With Observed FMP Plus Lipids and Subclinical CVD Measure (n=890) |
---|---|---|
Age at baseline, mean (SD), y | 46.41 (2.70) | 46.28 (2.66) |
Age at final menstrual period, mean (SD), y | 52.07 (2.85) | 52.15 (2.87) |
Race, n (%) | ||
White | 668 (43.0%) | 407 (45.7%) |
Black | 459 (29.5%) | 285 (32.0%) |
Chinese | 147 (9.5%) | 136 (15.3%) |
Hispanic | 108 (7.0%) | 62 (7.0%) |
Japanese | 172 (11.1%) | 0 |
Education, n (%) | ||
≤High school | 378 (24.55) | 208 (23.64) |
Some college | 492 (31.95) | 273 (31.02) |
College/Postgraduate | 670 (43.51) | 399 (45.34) |
Menopausal status, n (%) | ||
Premenopause | 884 (57.1%) | 521 (58.8%) |
Early perimenopause | 663 (42.9%) | 365 (41.2%) |
Lipid‐lowering medications, n (%) yes | 14 (0.9%) | 7 (0.8%) |
Body mass index, mean (SD), kg/m2 | 28.22 (7.39) | 28.33 (7.15) |
Smoking | ||
Never | 913 (58.8%) | 564 (63.4%) |
Former | 387 (24.9%) | 200 (22.5%) |
Current | 253 (16.3%) | 126 (14.2%) |
Estradiol, median (q1, q3), pg/mL | 55.12 (32.58, 87.08) | 55.12 (34.05, 86.25) |
Self‐reported prior angina or myocardial infarction | 20 (1.3%) | 0 |
Total cholesterol, mean (SD), mg/dL | 194.79 (34.49) | 192.92 (33.67) |
High‐density lipoprotein cholesterol, mean (SD), mg/dL | 56.39 (14.21) | 56.55 (13.81) |
Low‐density lipoprotein cholesterol, mean (SD) mg/dL | 116.34 (31.21) | 114.74 (30.22) |
Apo A1, mean (SD), mg/dL | 149.91 (24.05) | 150.00 (24.02) |
ApoB, mean (SD), mg/dL | 111.54 (30.07) | 109.96 (29.25) |
Triglycerides, median (q1, q3), mg/dL | 89 (65.00, 128.00) | 89 (64.00, 127.00) |
CVD indicates cardiovascular disease; and FMP: final menstrual period.